Medical technology: Change of board of directors – new boss of Carl Zeiss Meditec will start this year

Frankfurt. The timing for the change in boss at the medical technology group Carl Zeiss Meditec has been determined. CEO-designate Bronwyn Brophy O'Connor will take office on December 1, the company announced on Monday.

The manager's appointment was announced in May. However, the exact timing of her move still depended on negotiations with her previous employer, the Swedish reproductive medicine specialist Vitrolife.

Brophy O'Connor replaces Andreas Pecher, who has been leading the Jena ophthalmology specialist on an interim basis since the beginning of the year. Pecher is also the head of the unlisted parent company Carl Zeiss AG. He recently launched a savings program at the subsidiary that will lead to the reduction of up to 1,000 jobs.

When she takes office, Brophy O'Connor joins the parent company's board of directors and is responsible for the medical technology division. The Irishwoman has been working in the industry for more than 25 years and, before joining Vitrolife, worked for Thermo Fisher and Medtronic, among others.